Medifast officer plans to sell 9,545 shares

The planned sale consists of four stock-award lots acquired on dates ranging from October 3, 2018, through December 31, 2021.

Rhea-AI Filing Summary

Medifast, Inc. Officer Daniel R. Chard’s Form 144 notice lists a planned sale of 9,545 common shares, with an approximate aggregate market value of $114,337.80 and an approximate sale date of September 28, 2026. The remarks identify the shares as coming from the Daniel and Allyson Chard FAM IRRVOC TR. The notice lists four stock-award lots acquired on October 3, 2018, February 19, 2021, February 20, 2021, and December 31, 2021.

Key Figures

Common shares planned for sale: 9,545 shares Approximate aggregate market value: $114,337.80 Issuer shares outstanding: 11,180,703 shares +4 more

7 metrics

Common shares planned for sale 9,545 shares Approximate sale date: September 28, 2026

Approximate aggregate market value $114,337.80 For the planned sale

Issuer shares outstanding 11,180,703 shares Reported in the securities information

Stock-award lot 3,212 shares Acquired October 3, 2018

Stock-award lot 1,945 shares Acquired February 19, 2021

Stock-award lot 1,393 shares Acquired February 20, 2021

Stock-award lot 2,995 shares Acquired December 31, 2021

Key Terms

Rule 144, Stock Award, attorney-in-fact

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Award financial

"12/31/2021 | Stock Award | Issuer"

attorney-in-fact regulatory

"as attorney-in-fact for Daniel Chard"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MED shares is Daniel R. Chard planning to sell?

Daniel R. Chard’s proposed sale covers 9,545 common shares, with an approximate aggregate market value of $114,337.80. The approximate sale date is September 28, 2026.

What stock-award lots are included in the planned MED sale?

The notice lists four stock-award lots: 3,212 shares acquired October 3, 2018; 1,945 acquired February 19, 2021; 1,393 acquired February 20, 2021; and 2,995 acquired December 31, 2021. The remarks identify the shares as coming from the Daniel and Allyson Chard FAM IRRVOC TR.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 12:27 PM Accepted by SEC EDGAR 09/28/2026 - 12:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001289557
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MEDIFAST INC
SEC File Number	001-31573
Address of Issuer	1501 S. CLINTON STREET SUITE 500 BALTIMORE MARYLAND 21224
Phone	4105818042
Name of Person for Whose Account the Securities are To Be Sold	Chard Daniel R
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	9545	114337.80	11180703	09/28/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/31/2021	Stock Award	Issuer			2995	12/31/2021	n/a
Common Stock	10/03/2018	Stock Award	Issuer			3212	10/03/2018	n/a
Common Stock	02/19/2021	Stock Award	Issuer			1945	02/19/2021	n/a
Common Stock	02/20/2021	Stock Award	Issuer			1393	02/20/2021	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	shares are being sold from THE DANIEL AND ALLYSON CHARD FAM IRRVOC TR, U/A 10/12/21
Date of Notice	09/28/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Audrey Skillern as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Daniel Chard
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)